Clinical Trials Sponsored by Mylan Pharmaceuticals

Total 20563 results

Mylan Pharmaceuticals Inc

Completed

Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Finasteride Tablets 5 mg and Proscar® Tablets 5 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Terminated

Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Terminated

Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis

Atrophic Vaginitis

United States
Momenta Pharmaceuticals, Inc.
Mylan Inc.

Completed

Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects

Healthy Volunteers

United Kingdom
Mylan Pharmaceuticals Inc
Momenta Pharmaceuticals, Inc.

Completed

Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME) (DME)

Diabetic Macular Edema

Japan, United States, Czechia, Germany, Hungary, India, Latvia, Poland, Russian Federation
Mylan Pharmaceuticals Inc
Momenta Pharmaceuticals, Inc.

Completed

Extension Study of MYL-1701P-3001 for Safety and Efficacy

Diabetic Macular Edema

India
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State

Healthy

Canada
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State

Healthy

Canada
Mylan Pharmaceuticals Private Limited

Completed

A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee"

Osteoarthritis, Knee

India
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Comparative Bioavailability Study of Clarithromycin 250 mg Tablets

Healthy

Canada
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects

Therapeutic Equivalency

Canada
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects

Therapeutic Equivalency

Canada
Medical City Children's Hospital
Mylan Pharmaceuticals Inc

Terminated

Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation

Heart Defects, Congenital

United States
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State

Healthy

Canada
Mylan Inc.
Mylan GmbH

Completed

Phase I - Pharmacokinetic Comparability Study in Healthy Male Volunteers

Healthy

Netherlands
Mylan Inc.
Mylan GmbH

Completed

Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients

Type 1 Diabetes Mellitus

Czechia, United States, Canada, Estonia, Germany, Hungary, Latvia, Slovakia
Mylan Inc.
Mylan GmbH

Completed

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1) (INSTRIDE 1)

Type 1 Diabetes

United States, Canada, Czechia, Estonia, Germany, Hungary, Latvia, Romania, Slovakia, South Africa, United Kingdom
Mylan Inc.
Mylan GmbH

Completed

Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca. (HERiTAge)

Breast Cancer

Slovakia, Brazil, Chile, Georgia, Hungary, India, Latvia, Peru, Romania, Russian Federation, Serbia, South Africa, Thailand, Turkey, Ukraine
Mylan Inc.
Mylan GmbH

Completed

Adalimumab PK Bioequivalence Study to EU and US Sourced Humira

Healthy Volunteers

Belgium
Mylan Inc.
Mylan GmbH

Completed

Efficacy and Safety Study With MYL-1401H and Neulasta

Breast Neoplasms | Chemotherapy-Induced Febrile Neutropenia

Bulgaria, Georgia, Germany, Hungary, Poland, Ukraine
Mylan Inc.
Mylan GmbH

Completed

Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta

Healthy Volunteers

Netherlands
Mylan Inc.
Mylan GmbH

Completed

MYL-1401A Efficacy and Safety Comparability Study to Humira®

Psoriasis | Arthritis, Psoriatic

Bulgaria, Estonia, Hungary, Poland, Russian Federation, Ukraine
Mylan Inc.
Mylan GmbH

Completed

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2) (INSTRIDE 2)

Type 2 Diabetes

United States, Jordan, Korea, Republic of, Slovakia, South Africa, Taiwan
Mylan Inc.
Mylan GmbH

Completed

Mylan Insulin Glargine Study

Diabetes Mellitus, Type 1

United States
Mylan Inc.
Mylan GmbH

Completed

Mylan Insulin Aspart Study

Diabetes Mellitus, Type 1

United States
Mylan Inc.
Taisho Pharmaceutical Co., Ltd.

Completed

Special Investigation of Clarith/Klaricid in Patients With Non-tuberculous Mycobacterial Pulmonary Infections

Mycobacterium Infections, Atypical

Japan
Mylan Inc.
Mylan Österreich GmbH; Mylan Germany GmbH; Mylan Healthcare Sp. z o.o.

Completed

Observation of the Effects of Guideline-driven Lifestyle Interventions, Including Use of a Red-yeast Based Nutraceutical

Hypercholesterolemia

Germany, Austria
Mylan Technologies Inc.
Mylan Inc.

Active, not recruiting

Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Contraception

United States, Canada, Puerto Rico
University of California, Los Angeles
Mylan Pharmaceuticals Inc; Theravance Biopharma

Recruiting

Revefenacin in Acute Respiratory Insufficiency in COPD (RARICO)

COPD | Acute Respiratory Failure

United States
Mylan (Taiwan) Ltd

Completed

Efficacy and Safety of Ricovir® in Maintaining Durability of Viral Response in Chronic Hepatitis B Patients Who Have Been Treated With Viread® and Have Undetectable HBV DNA in Serum

Chronic Hepatitis B Infection

Taiwan
University of Tennessee Graduate School of Medicine
Mylan Pharmaceuticals Inc

Recruiting

Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD

COPD Exacerbation

United States
Mylan Inc.

Completed

Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain

Pain | Postoperative Pain | Pain, Acute

United States
Mylan Inc.

Completed

A Survey on Efficacy and Safety in Patients With Endometriosis

Endometriosis

Japan
Mylan Inc.

Completed

Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency

Digestive System Diseases | Pancreatic Diseases | Exocrine Pancreatic Insufficiency

Japan
Mylan Inc.

Completed

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Digestive System Diseases | Pancreatic Diseases | Cystic Fibrosis | Exocrine Pancreatic Insufficiency

Japan
Forest Laboratories
Mylan Laboratories

Terminated

Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-release (ER) for Hypertension

Hypertension

United States
Mylan Inc.

Completed

Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules

Cystic Fibrosis

United States
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan

3

Subscribe